Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathies

Annals of the New York Academy of Sciences

Volumn 883, Issue , 1999, Pages 310-320

  Zielasek, Jürgen ^a   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; PMP22 PROTEIN, HUMAN; PMP22 PROTEIN, MOUSE;

ANIMAL; ARTICLE; GENETICS; GENOTYPE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; INNERVATION; MOUSE; MOUSE MUTANT; MYELIN SHEATH; NERVE CONDUCTION; NERVE FIBER; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; AXONS; CHARCOT-MARIE-TOOTH DISEASE; GENOTYPE; HUMANS; MICE; MICE, KNOCKOUT; MICE, NEUROLOGIC MUTANTS; MUSCLE, SKELETAL; MYELIN P0 PROTEIN; MYELIN PROTEINS; MYELIN SHEATH; NEURAL CONDUCTION;

EID: 0033554303     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08593.x     Document Type: Article

References (34)

1. REILLY, M. M. 1998. Genetically determined neuropathies. J. Neurol. 245: 6-13.
2. MARTINI, R. 1997. Animal models for inherited peripheral neuropathies. J. Anat. 191: 321-336.
3. MARTINI, R., J. ZIELASEK & K.V. TOYKA. 1998. Inherited demyelinating neuropathies: from gene to disease. Curr. Opin. Neurol. 11: 545-556.
4. 0 gene mutations. Muscle Nerve 19: 946-952.
5. ADLKOFER, K., R. MARTINI, A. AGUZZI, et al. 1995. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat. Genet. 11: 274-280.
6. ADLKOFER, K., R. FREI, D. H. NEUBERG, et al. 1997. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J. Neurosci. 17: 4662-4671.
7. GOUIDER, R., G. E. LE, M. GUGENHEIM, et al. 1995. Clinical, electrophyslologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology 45: 2018-2023.
8. MAGYAR, J. P., R. MARTINI, T. RUELICKE, et al. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16: 5351-5360.
9. SEREDA, M., I. GRIFFITHS, A. PUHLHOFER, et al. 1996. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16: 1049-1060.
10. HUXLEY, C., E. PASSAGE, A. MANSON, et al. 1996. Construction of a mouse model of Charcot-Marie-Tooth disease type IA by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5: 563-569.
11. MAGYAR, J. P., R. MARTINI, T. RUELICKE, et al. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16: 5351-5360.
12. HUXLEY, C., E. PASSAGE, A. M. ROBERTSON, et al. 1998. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum. Mol. Genet. 7: 449-458.
13. BIROUK, N., R. GOUIDER, G. E. LE, et al. 1997. Charcot-Marie-Tooth disease type IA with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 120: 813-823.
14. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71: 565-576.
15. 0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat. Genet. 11: 281-286.
16. NELLES, E., C. BUTZLER, D. JUNG, et al. 1996. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc. Natl. Acad. Sci. USA 93: 9565-9570.
17. ANZINI, P., D. H. NEUBERG, M. SCHACHNER, et al. 1997. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J. Neurosci. 17: 4545-4551.
18. TOYKA, K. V., J. ZIELASEK, K. RICKER, et al. 1997. Hereditary neuromyotonia: a mouse model associated with deficiency or increased gene dosage of the PMP22 gene [letter]. J. Neurol. Neurosurg. Psychiatry 63: 812-813.
19. SUTER, U., A. A. WELCHER, T. OZCELIK, et al. 1992. Trembler mouse carries a point mutation in a myelin gene. Nature 356: 241-244.
20. SUTER, U., J. J. MOSKOW, A. A. WELCHER, et al. 1992. A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc. Natl. Acad. Sci. USA 89: 4382-4386.
21. LOW, P. A. & J. G. MCLEOD. 1975. Hereditary demyelinating neuropathy in the trembler mouse. J. Neurol. Sci. 26: 565-574.
22. LOW, P. A. & J. G. MCLEOD. 1977. Refractory period, conduction of trains of impulses, and effect of temperature on conduction in chronic hypertrophic neuropathy. J. Neurol. Neurosurg. Psychiatry 40: 434-447.
23. FALCONER, D. S. 1951. Two new mutants, "trembler" and "recler," with neurological actions in the house mouse (Mus musculus L.). J. Genet. 50: 192-201.
24. AYERS, M. M. & R. MCD. ANDERSON. 1973. A model of hypertrophic interstitial neuropathy (Dejerine-Sottas) in man. Acta Neuropathol. (Berlin) 25: 54-70.
25. ISAACS, H. 1961. A syndrome of continuous muscle-fibre activity. J. Neurol. Neurosurg. Psychiatry 24: 319-325.
26. MERTENS, H. G. & S. ZSCHOCKE. 1965. Neuromyotonie. Klin. Wochenschr. 43: 917-925.
27. AUGER, R. G. 1994. AAEM minimonograph 44: diseases associated with excess motor unit activity. Muscle Nerve 17: 1250-1263.
28. SINHA, S., J. NEWSOM-DAVIS, K. MILLS, et al. 1991. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) Lancet 338: 75-77.
29. LANCE, J. W. 1988. Association of lower motor neuron disorders with fasciculation, neuromyotonia and myoclonus. Aust. Paediatr. J. 24(Suppl. 1): 113-115.
30. LANCE, J. W., D. BURKE & J. POLLARD. 1979. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann. Neurol. 5: 523-532.
31. CARDOSO, F. E. & J. JANKOVIC. 1993. Hereditary motor-sensory neuropathy and movement disorders. Muscle Nerve 16: 904-910.
32. HARDING, A. E. & P. K. THOMAS. 1980. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103: 259-280.
33. WAXMAN, S. G., J.D. KOCSIS & J.A. BLACK. 1995. Pathophysiology of demyelinated axons. In The Axon: Structure, Function and Pathophysiology. S. G. Waxman, J. D. Kocsis & P. K. Stys, Eds.: 438-461. Oxford University Press, New York.
34. DEVOR, M. 1995. Abnormal excitability in injured axons. In The Axon. Structure, Function and Pathophysiology. S.G. Waxman, J.D. Kocsis & P.K. Stys, Eds.: 530-552. Oxford University Press, New York.